Simplistic Summary of Efficacy Data

Rates of global improvement generally more similar than different across trials with different agents:

65+/-% drug

30 – 50+/-% placebo

Unproven whether target symptoms matter

Previous slide

Next slide

Back to first slide

View graphic version